Breaking News Instant updates and real-time market news.

ICPT

Intercept

$98.12

1.92 (2.00%)

13:41
09/21/17
09/21
13:41
09/21/17
13:41

Intercept selloff continues, shares down over 15% to $83.35

ICPT Intercept
$98.12

1.92 (2.00%)

09/21/17
LEER
09/21/17
NO CHANGE
LEER
Market Perform
FDA could tilt toward black box warning for Intercept's Ocaliva, says Leerink
Leerink analyst Joseph Schwartz noted the FDA issued a new warning letter about liver injury risk with Intercept's Ocaliva that echoes much of the same content as the last week's "Dear Doctor" letter, but includes a warning that pertains to a larger portion of PBC patients. The FDA's mention of 19 deaths and worsening of PBC cases is "particularly concerning" and could tilt it toward a black box warning for the drug, added Schwartz. The analyst, who thinks Ocaliva adoption in PBC patients could face headwinds from safety issues, keeps a Market Perform rating on Intercept shares, which are down about 9% near noon.
09/20/17
JEFF
09/20/17
NO CHANGE
Target $275
JEFF
Buy
Intercept recent pullback a buying opportunity, says Jefferies
After hosting investor meetings with management, Jefferies analyst Michael Yee says the recent pullback in shares of Intercept Pharmaceuticals creates a buying opportunity. The analyst left the meetings more confident that the Street's reaction to the patient safety letter "was overblown and likely to subside." The stock is near a "floor valuation" of $80-$100 and gives no credit to nonalcoholic steatohepatitis in 2019, Yee tells investors in a research note. He keeps a Buy rating on Intercept with a $275 price target.
09/19/17
SBSH
09/19/17
NO CHANGE
Target $150
SBSH
Buy
Concern over Intercept 'Dear Doctor' letter overblown, says Citi
After finding 10 other drugs that have been the subject of a "Dear Doctor" letter related to liver toxicity issues, Citi analyst Joel Beatty believes concern over Intercept Pharmaceuticals' patient safety letter on Ocaliva is overblown. The risk that Ocaliva will be withdrawn from the market is "very low," and the risk that the drug will get a black box warning isn't as much of a given as it first appear, Beatty tells investors in a research note. Further, he believes the drug can still be commercially successful even with a black box warning. The analyst keeps a Buy rating on Intercept with a $150 price target.
09/14/17
RBCM
09/14/17
INITIATION
Target $244
RBCM
Outperform
Intercept initiated with an Outperform at RBC Capital
RBC Capital analyst Brian Abrahams started Intercept Pharmaceuticals with an Outperform rating and $244 price target. After speaking to physicians, the analyst believes Ocaliva's prospects in cholestatic disease are underappreciated and the drug's long-term potential in nonalcoholic Steatohepatitis "could be substantial." He views the stock as "meaningfully undervalued."

TODAY'S FREE FLY STORIES

XENE

Xenon Pharmaceuticals

$3.60

-0.025 (-0.69%)

08:37
02/20/18
02/20
08:37
02/20/18
08:37
Hot Stocks
Xenon Pharmaceuticals initiates Phase 1 clinical trial of XEN901 »

Xenon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHMG

Chemung Financial

$43.90

0.09 (0.21%)

08:37
02/20/18
02/20
08:37
02/20/18
08:37
Upgrade
Chemung Financial rating change  »

Chemung upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$104.78

1.55 (1.50%)

08:36
02/20/18
02/20
08:36
02/20/18
08:36
Hot Stocks
Walmart sees ecommerce losses 'about the same' in FY19 vs. FY18 »

Walmart CFO Brett Biggs,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

  • 07

    Mar

HII

Huntington Ingalls

$265.70

10.31 (4.04%)

08:36
02/20/18
02/20
08:36
02/20/18
08:36
Recommendations
Huntington Ingalls analyst commentary  »

Huntington Ingalls price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ECL

Ecolab

$131.49

-0.28 (-0.21%)

08:35
02/20/18
02/20
08:35
02/20/18
08:35
Earnings
Ecolab sees FY18 adjusted EPS $5.25-$5.45, consensus $5.34 »

The 2018 outlook shown…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 30

    May

GPC

Genuine Parts

$99.83

-1.08 (-1.07%)

08:35
02/20/18
02/20
08:35
02/20/18
08:35
Hot Stocks
Genuine Parts reports Q4 sales for Automotive Group up 16.7% »

Fourth quarter sales for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

IMAX

Imax

$22.60

-0.3 (-1.31%)

08:34
02/20/18
02/20
08:34
02/20/18
08:34
Hot Stocks
Imax announces record $35M global debut of Marvel Studios' Black Panther »

IMAX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 05

    Mar

EXPD

Expeditors

$64.12

-0.07 (-0.11%)

08:33
02/20/18
02/20
08:33
02/20/18
08:33
Earnings
Expeditors reports Q4 EPS 92c, consensus 63c »

Reports Q4 revenue $1.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADI

Analog Devices

$86.09

0.69 (0.81%)

08:33
02/20/18
02/20
08:33
02/20/18
08:33
Upgrade
Analog Devices rating change  »

Analog Devices upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

GPC

Genuine Parts

$99.83

-1.08 (-1.07%)

08:32
02/20/18
02/20
08:32
02/20/18
08:32
Earnings
Genuine Parts sees FY18 EPS $5.60-$5.75, consensus $5.93 »

The company is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

ECL

Ecolab

$131.49

-0.28 (-0.21%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Earnings
Ecolab reports Q4 adjusted EPS $1.39, consensus $1.39 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 30

    May

SMP

Standard Motor

$48.20

0.3 (0.63%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Earnings
Standard Motor reports Q4 cont ops EPS 54c, consensus 38c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$172.43

-0.56 (-0.32%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Technical Analysis
Technical Take: Apple slips in early trading »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

GPC

Genuine Parts

$99.83

-1.08 (-1.07%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Earnings
Genuine Parts reports Q4 adjusted EPS $1.19, consensus $1.05 »

Reports Q4 revenue $4.2B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

GPS

Gap

$33.27

-0.06 (-0.18%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Hot Stocks
Gap announces departure of Gap brand President and CEO Jeff Kirwan »

Gap Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 18

    Mar

ANY

Sphere 3D

$2.33

0.0999 (4.48%)

, FALC

FalconStor

$0.19

0.003 (1.65%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Options
Two option delistings on February 20th »

Option delistings…

ANY

Sphere 3D

$2.33

0.0999 (4.48%)

FALC

FalconStor

$0.19

0.003 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RUSHA

Rush Enterprises

$42.77

-0.325 (-0.75%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Recommendations
Rush Enterprises analyst commentary  »

Rush Enterprises price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:29
02/20/18
02/20
08:29
02/20/18
08:29
General news
Stocks point to lower start to week as Walmart weighs on Dow »

Stock futures are…

GOOD

Gladstone

$17.65

0.24 (1.38%)

08:28
02/20/18
02/20
08:28
02/20/18
08:28
Hot Stocks
Gladstone announces sale of Arlington, TX $5.6M »

Gladstone announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAN

Aaron's

$43.40

-0.39 (-0.89%)

, LOW

Lowe's

$96.31

-0.2 (-0.21%)

08:28
02/20/18
02/20
08:28
02/20/18
08:28
Recommendations
Aaron's, Lowe's analyst commentary  »

Aaron's Progressive…

AAN

Aaron's

$43.40

-0.39 (-0.89%)

LOW

Lowe's

$96.31

-0.2 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 07

    Mar

LVMUY

LVMH

$61.94

0.68 (1.11%)

08:27
02/20/18
02/20
08:27
02/20/18
08:27
Hot Stocks
LVMH names Serge Brunschwig as Chairman and CEO of Fendi »

The LVMH Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$77.27

2.66 (3.57%)

08:26
02/20/18
02/20
08:26
02/20/18
08:26
Earnings
Wabtec reports Q4 adj. EPS 90c, consensus 92c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Mar

ATNX

Athenex

$16.66

-0.11 (-0.66%)

08:25
02/20/18
02/20
08:25
02/20/18
08:25
Hot Stocks
Athenex announces Phase II clinical study results for KX2-391 ointment »

Athenex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

08:25
02/20/18
02/20
08:25
02/20/18
08:25
General news
Fedspeak is backloaded during the week: »

Fedspeak is backloaded…

IPGP

IPG Photonics

$239.36

-19.71 (-7.61%)

08:23
02/20/18
02/20
08:23
02/20/18
08:23
Recommendations
IPG Photonics analyst commentary  »

IPG Photonics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.